How Combination Therapies with JAK Inhibitors May Change MPN Treatment

patientpower has 2398 videos Subscribe Here

Description: Soon there will be multiple JAK2 inhibitor drugs on the market. Will they make a difference for polycythemia vera (PV) and essential thrombocythemia (ET) patients? And how significant are they in treating myelofibrosis? Leading European expert Dr. Francisco Cervantes talks about how this class of drugs may be used alone or in combination to improve MPN outcomes. Watch now.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 05/15/13
Added : 5 years ago
Category : General